Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 4 3Phase 3 3Phase NA 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Brain Neoplasms 2Seizures 1Glioma 1Epilepsy 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Levetiracetam × Clear all
NCT03048084 2025-02-04

STING

Leiden University Medical Center

Phase 4 Recruiting
120 enrolled
CNS

Glioma

NCT02334722 2021-12-15

1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients

University of Florida

Phase 4 Completed
81 enrolled 10 charts
CNS

Brain Neoplasms, Seizures

NCT00571155 2009-08-20

Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery

University Hospital Tuebingen

Phase 4 Completed
30 enrolled
CNS

Brain Neoplasms, Epilepsy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡